Zofran
Sponsors
Par Pharmaceutical, Inc., Rigshospitalet, Denmark, Hartford Hospital, M.D. Anderson Cancer Center, INSYS Therapeutics Inc
Conditions
AnesthesiaBreast CancerChlorzoxazoneConstipationHealthyNarcotic UseNauseaOpioid Use
Phase 1
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions
CompletedNCT00653458
Start: 2002-08-31End: 2002-09-30Updated: 2008-04-11
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions
CompletedNCT00654277
Start: 2002-08-31End: 2002-09-30Updated: 2008-04-11
Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions
CompletedNCT00659074
Start: 2003-10-31End: 2004-02-29Updated: 2008-04-16
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
CompletedNCT03973047
Start: 2019-06-17End: 2019-07-20Updated: 2022-04-04
Phase 2
Phase 4
The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery
CompletedNCT01933542
Start: 2013-08-31End: 2015-08-31Updated: 2015-09-17
The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery
CompletedNCT01953978
Start: 2012-12-31End: 2015-09-30Updated: 2015-10-27
Decreasing Narcotics in Advanced Pelvic Surgery
CompletedNCT02110719
Start: 2014-03-31End: 2016-06-30Updated: 2016-08-17
PROUD Study - Preventing Opioid Use Disorders
TerminatedNCT04766996
Start: 2021-05-17End: 2021-12-27Updated: 2023-06-22